Plasma and urinary metabolites of efonidipine hydrochloride in man

References

• Beresford A. P., Macrae P. V., Stopher D. A. Metabolism of amlodipine in the rat and the dog: a species difference. Xenobiotica 1988; 18: 169–182
   PubMed Web of Science ®Google Scholar
• Grossi P., Pellegatti M., Vigelli G., Ayrton J., Duncan B. A., Evans G. L., Maltas J. Lacidipine metabolism in rat and dog: identification and synthesis of main metabolites. Xenobiotica 1992; 22: 899–916
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Macdonald T. L. Chemical mechanisms of catalysis of cytochromes P-450: a unified view. Accounts of Chemical Research 1984; 17: 9–16
   Web of Science ®Google Scholar
• Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
   PubMed Web of Science ®Google Scholar
• Hoffmann K. J, Weidolf L. Identification of felodipine metabolites in rat urine. Biomedical Mass Spectrometry 1985; 12: 414–423
   PubMedGoogle Scholar
• Kobayasi H., Okumura S., Kosaka Y., Kobayashi S., Inoue A., Oka T., Nakamizo N. Identification of benedipine hydrochloride metabolites in rats and dogs. Arzneimittel-Forschung/Drug Research 1988; 38: 1753–1756
   Google Scholar
• Lindeke B., Cho A. K. N-dealkylation and deamination. Metabolic Basis of Detoxication: Metabolism of Functional Groups, W. B. Jakoby, J. R. Bend, J. Caldwell. Academic, New York 1982; 105–126
   Google Scholar
• Masuda Y., Takeguchi M., Arakawa C., Sakai T., Hibi M., Tanaka S., Shigenobu K., Kasuya Y. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Archives internationales de Pharmacodynamic et de Thérapie 1990; 304: 247–264
   Google Scholar
• Medenwald V. H., Schloßmann K., Wünsche C. Strukturaufklärung der renalen Ausscheidungsprodukte von 4-(2′-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonsauredimethyl ester. Arzneimittel-Forschung/Drug Research 1972; 22: 53–56
   PubMed Web of Science ®Google Scholar
• Meyer H., Scherling D., Karl W. Nitrendipine: identification and synthesis of main metabolites. Arzneimittel-Forschung/Drug Research 1983; 33: 1528–1534
   PubMed Web of Science ®Google Scholar
• Meyer H., Wehinger E., Bossert F., Scherling D. Nimodipine: synthesis and metabolic pathway. Arzneimittel-Forschung/Drug Research 1983; 33: 106–112
   PubMed Web of Science ®Google Scholar
• Nakabeppu H., Nakajima A., Kamikawaji Y., Shinozaki Y. Identification of efonidipine hydrochloride metabolites in rats. Arzneimittel-Forschung/Drug Research 1995; 45: 766–770
   Google Scholar
• Nakashima M., Kanamaru M., Uematsu T., Sato R., Mizuno A., Nagashima S., Takiguchi S., Tanaka S., Hibi M., Saito T., Yoshida Y. Pharmacokinetics and safety of NZ-105 in healthy volunteers: single-dose and multipole-dose studies. Japanese Journal of Clinical Pharmacology and Therapeutics 1991; 22: 673–683
   Google Scholar
• Ogawa N., Mizuno K., Fukushima K., Suwa T., Satou T. Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog. Xenobiotica 1993; 23: 747–759
   PubMed Web of Science ®Google Scholar
• Parinov V. J., Odinec A. G., Gilev A. P., Dubur G. J., Muceniece D. H., Ozol J. J., Shatz V. D., Gavars M. P., Vigante B. A. Pharmacokinetics and metabolism of ryodipine in rats. Arzneimittel-Forschung/Drug Research 1985; 35: 808–813
   PubMed Web of Science ®Google Scholar
• Parker S., Weinstock J. Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Medical Chemistry 1973; 16: 34–37
   PubMed Web of Science ®Google Scholar
• Rush W. R., Alexander O., Hall D. J., Cairncross L., Dow R. J., Graham D. J. G. The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica 1986; 16: 341–349
   PubMed Web of Science ®Google Scholar
• Scherling D., Karl W., Ahr G., Ahr H. J., Wehinger E. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man. Arzneimittel-Forschung/Drug Research 1988; 38: 1105–1110
   PubMed Web of Science ®Google Scholar
• Shinozaki Y., Himori Y., Sano H., Nakabeppu H., Oda T., Esumi Y., Seki H. Studies on the metabolic fate of NZ-105 (1): absorption, distribution, metabolism and excretion after a single administration to rats. Xenobiotic Metabolism and Disposition 1991a; 6: 919–932
   Google Scholar
• Shinozaki Y., Himori Y., Sano H., Nakabeppu H., Oda T., Esumi Y., Seki H. Studies on the metabolic fate of NZ-105 (III): absorption, metabolism and excretion in dogs and protein binding. Xenobiotic Metabolism and Disposition 1991b; 6: 945–953
   Google Scholar
• Takayama F., Iwasawa Y., Saito K., Shiratori K., Ohtawa M. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Xenobiotica 1989; 19: 1407–1420
   PubMed Web of Science ®Google Scholar
• Tamura T., Saigusa A., Kokubun S. Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line. Naunyu-Schmiedeberg's Archives of Pharmacology 1991; 343: 405–410
   Google Scholar
• Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1415–1425
   PubMed Web of Science ®Google Scholar
• Weidolf L., Borg K. O., Hoffmann K. -J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666
   PubMed Web of Science ®Google Scholar
• Yeh S. Y. N-depyridination and N-dedimethylaminoethylation of tripelennamine and pyrilamne in the rat. Drug Metabolism and Disposition 1990; 18: 453–461
   PubMed Web of Science ®Google Scholar